Duloxetine increases stage 3 sleep and suppresses rapid eye movement (REM) sleep in patients with major depression

被引：50
作者：
Kluge, Michael [1 ]
Schussler, Petra [1 ]
Steiger, Axel [1 ]
机构：
[1] Max Planck Inst Psychiat, Munich, Germany
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2007年 / 17卷 / 08期
关键词：
duloxetine; REM sleep; stage; 2; sleep; major depression;
D O I：
10.1016/j.euroneuro.2007.01.006
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Sleep studies in patients with major depression receiving the new selective norepinephrine and serotonin reuptake inhibitor (SNRI) dutoxetine are lacking. Therefore, polysomnography in 10 patients with major depression (7 mates, 39.9 +/- 7.6 years, HAMD-21 score: 23.6 5.6) was recorded twice, before and after 7-14 days of treatment with duloxetine. Stage 3 steep significantly (P<0.01) increased from 21.0 +/- 10.7 to 37.4 +/- 20.1 min. Rapid eye movement (REM) latency significantly (P<0.005) increased from 58.5 +/- 31.1 to 193.6 +/- 72.6 min. REM steep significantly (P<0.005) decreased from 94.8 +/- 34.5 to 51.5 +/- 42.5 min. These results partly differ from those in healthy subjects receiving duloxetine. (c) 2007 Elsevier B.V. and ECNR Alt rights reserved.
引用
收藏
页码：527 / 531
页数：5
相关论文
共 35 条
[1]   A multicenter, double-blind comparison of the effects of nefazodone and fluoxetine on sleep architecture and quality of sleep in depressed outpatients [J].
Armitage, R ;
Yonkers, K ;
Cole, D ;
Rush, AJ .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1997, 17 (03) :161-168
[2]   A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder [J].
Arnold, LM ;
Lu, YL ;
Crofford, LJ ;
Wohlreich, M ;
Detke, MJ ;
Iyengar, S ;
Goldstein, DJ .
ARTHRITIS AND RHEUMATISM, 2004, 50 (09) :2974-2984
[3]   Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors [J].
Bymaster, FP ;
Dreshfield-Ahmad, LJ ;
Threlkeld, PG ;
Shaw, JL ;
Thompson, L ;
Nelson, DL ;
Hemrick-Luecke, SK ;
Wong, DT .
NEUROPSYCHOPHARMACOLOGY, 2001, 25 (06) :871-880
[4]   Comparative effects of duloxetine and desipramine on sleep EEG in healthy subjects [J].
Chalon, S ;
Pereira, A ;
Lainey, E ;
Vandenhende, F ;
Watkin, JG ;
Staner, L ;
Granier, LA .
PSYCHOPHARMACOLOGY, 2005, 177 (04) :357-U5
[5]   Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial [J].
Detke, MJ ;
Wiltse, CG ;
Mallinckrodt, CH ;
McNamara, RK ;
Demitrack, MA ;
Bitter, I .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 (06) :457-470
[6]   Duloxetine compared with fluoxetine and venlafaxine: use of meta-regression analysis for indirect comparisons [J].
Eckert, Laurent ;
Lancon, Christophe .
BMC PSYCHIATRY, 2006, 6 (1)
[7]   Fluoxetine and sleep EEG: Effects of a single dose, subchronic treatment, and discontinuation in healthy subjects [J].
Feige, B ;
Voderholzer, U ;
Riemann, D ;
Dittmann, R ;
Hohagen, F ;
Berger, M .
NEUROPSYCHOPHARMACOLOGY, 2002, 26 (02) :246-258
[8]   TRIMIPRAMINE - ACUTE AND LASTING EFFECTS ON SLEEP IN HEALTHY AND MAJOR DEPRESSIVE SUBJECTS [J].
FEUILLADE, P ;
PRINGUEY, D ;
BELUGOU, JL ;
ROBERT, P ;
DARCOURT, G .
JOURNAL OF AFFECTIVE DISORDERS, 1992, 24 (03) :135-146
[9]   RELATIONSHIP BETWEEN CHANGES IN REM-SLEEP AND CLINICAL IMPROVEMENT IN DEPRESSED-PATIENTS TREATED WITH AMITRIPTYLINE [J].
GILLIN, JC ;
WYATT, RJ ;
FRAM, D ;
SNYDER, F .
PSYCHOPHARMACOLOGY, 1978, 59 (03) :267-272
[10]   Duloxetine vs. placebo in patients with painful diabetic neuropathy [J].
Goldstein, DJ ;
Lu, YL ;
Detke, MJ ;
Lee, TC ;
Iyengar, S .
PAIN, 2005, 116 (1-2) :109-118
1234